eris lifesciences
-
Business
Eris to buy Biocon arm’s branded drugs for 1,242 crore – Times of India
[ad_1] NEW DELHI: Biocon is selling branded formulations of its subsidiary Biocon Biologics to Eris Lifesciences for Rs 1,242 crore.…
Read More » -
Business
Eris to buy Biocon arm’s brands in Rs 366 crore deal – Times of India
[ad_1] NEW DELHI: Biocon Biologics (BBL) is divesting its dermatology and nephrology branded formulations business to Eris Lifesciences for Rs…
Read More » -
Business
Breakout Stocks: How are Eris Lifesciences, Aurobindo Pharma and NTPC looking on charts for Tuesday’s trade?
[ad_1] The Indian market bounced back on Friday after falling nearly 1% in the previous trading session. The S&P BSE…
Read More »
